OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

AddThis Feed Button

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08

« FDA Requests Comments on 180-Day Exclusivity for Generic Altace (Ramipril) | Main | Federal Circuit Affirms Injunction Against Apotex in Depakote Case, But Finds Apotex Was Not in Contempt »

October 10, 2007

iiBIG "New Directions for Drug Delivery" Conference, Las Vegas, October 29-30

The International Institute for Business Information & Growth will hold a conference entitled "New Directions for Drug Delivery," October 29-30 in Las Vegas, Nevada.  The conference is designed for pharmaceutical scientists and specialty pharma, biopharmaceutical, and nanotechnology licensing and business development team leaders.  According to iiBIG, attendees will learn "how new scientific technologies are driving investments, alliances and clinical trials to bring novel drug delivery technologies to market."

The agenda includes several interesting sessions, including:

  • "Rapid Evaluation of Drug Delivery Technologies"
  • "FDA & Patents -- Case Study of Transdermal Patches"
  • "Innovations and Success Strategies: Learning and Un-learning from Key Players" (a panel on which I'll be speaking)
  • "Eye on the Future -- Breakthrough Scientific and Partnership Strategies"
  • "Converting from Drug Delivery to Specialty Pharma -- The Road More Traveled"

For more information or to register, please visit the conference website.

Orange Book Blog is a media partner of this conference.

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.